When the Hives of CSU Don ’t Go Away on Their Own
CSU can be frustrating, but the worst part might be when the hives don’t go away on their own. New treatments can help. (Source: WebMD Health)
Source: WebMD Health - October 21, 2022 Category: Consumer Health News Source Type: news
How Chronic Spontaneous Urticaria Is Different
Hives themselves are very common. So what sets chronic spontaneous urticaria apart? (Source: WebMD Health)
Source: WebMD Health - October 21, 2022 Category: Consumer Health News Source Type: news
Chronic Spontaneous Urticaria: What to Know
What you should know about chronic spontaneous urticaria (CSU), including symptoms, triggers, treatment, and a link to autoimmune disease. (Source: WebMD Health)
Source: WebMD Health - October 21, 2022 Category: Consumer Health News Source Type: news
[Ad hoc announcement pursuant to Art. 53 LR] Roche records solid results for the first nine months of 2022
Group salesup 2%[1] at constant exchange rates (CER) and 1% in Swiss francs; as expected, significantly lower COVID-19-related sales in both divisions in the third quarterSales in the Pharmaceuticals Divisionat the previous year ’s level with significantly lower sales of COVID-19-related products (Ronapreve and Actemra/RoActemra) and losses to biosimilars, offset by strong growth of newer medicinesSales in the Diagnostics Divisionrise 6%; base business remains strong; as expected, demand for COVID-19 tests sharply down in third quarterHighlights in the third quarter:EU approval forVabysmo (severe eye diseases)US approval...
Source: Roche Investor Update - October 18, 2022 Category: Pharmaceuticals Source Type: news
[Ad hoc announcement pursuant to Art. 53 LR] Roche records solid results for the first nine months of 2022
Basel, 18 October 2022Group salesup 2%1 at constant exchange rates (CER) and 1% in Swiss francs; as expected, significantly lower COVID-19-related sales in both divisions in the third quarterSales in the Pharmaceuticals Divisionat the previous year ’s level with significantly lower sales of COVID-19-related products (Ronapreve and Actemra/RoActemra) and losses to biosimilars, offset by strong growth of newer medicinesSales in the Diagnostics Divisionrise 6%; base business remains strong; as expected, demand for COVID-19 tests sharply down in third quarterHighlights in the third quarter:EU approval forVabysmo (severe eye ...
Source: Roche Media News - October 18, 2022 Category: Pharmaceuticals Source Type: news
Urticaria During Pregnancy: Study Analyzes Outcomes, Treatments Urticaria During Pregnancy: Study Analyzes Outcomes, Treatments
The study involved 288 pregnancies in women with chronic urticaria who were part of an international, multicenter study of the Urticaria Centers of Reference and Excellence (UCARE) network.MDedge News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - October 12, 2022 Category: Allergy & Immunology Tags: Dermatology News Source Type: news
Results of Novel Clinical Study of Guselkumab and Golimumab Combination Therapy Show Adults with Moderately to Severely Active Ulcerative Colitis Maintained Higher Rates of Clinical, Histologic, and Endoscopic Remission at Week 38
SPRING HOUSE, PENNSYLVANIA, October 10, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced data from an ongoing analysis of a Phase 2a clinical trial showing adults with moderately to severely active ulcerative colitis (UC) who received 12 weeks of combination induction therapy with guselkumab and golimumab, followed by a transition to guselkumab alone for maintenance, achieved a clinical remission ratea (based on the modified Mayo score [mMayo])b at week 38 of 47.9 percent, a higher rate than induction and maintenance treatment with either guselkumab alone (31.0 percent) or golimumab al...
Source: Johnson and Johnson - October 10, 2022 Category: Pharmaceuticals Source Type: news
Teen girl, 14, develops allergy to WATER that makes getting wet feel like 'being set on fire'
Sadie Tessmer, 14, from Buffalo in Missouri, sees her skin break out in painful red hives every time she showers. She has quit soccer too, because the sweat causes her the reaction. (Source: the Mail online | Health)
Source: the Mail online | Health - September 20, 2022 Category: Consumer Health News Source Type: news
Anti-IgE Therapy Found Safe and Effective for Chronic Urticaria Anti-IgE Therapy Found Safe and Effective for Chronic Urticaria
Both doses of ligelizumab evaluated met the primary endpoint of superiority to placebo for a complete response at 16 weeks of therapy.MDedge News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - September 15, 2022 Category: Internal Medicine Tags: Dermatology News Source Type: news
TREMFYA ®▼ (guselkumab) Demonstrates Higher Rates of Complete Skin Clearance with Earlier Treatment in Adults with Moderate to Severe Plaque Psoriasis in Phase 3b GUIDE Study
Beerse, Belgium, 8 September 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new data for TREMFYA®▼(guselkumab) from the ongoing Phase 3b GUIDE study, which is designed to understand the impact of early intervention and potential dosing interval flexibility on the long-term disease course in adult patients with moderate to severe plaque psoriasis (Pso). These new data demonstrated that “super responders”a to guselkumab who received every-16-week dosingb maintained disease control (absolute Psoriasis Area and Severity Index [PASI] score <3) at a rate that was non-inferior to ...
Source: Johnson and Johnson - September 8, 2022 Category: Pharmaceuticals Tags: Latest News Source Type: news
What Caused This Summer Birthday Party Rash?
Discussion
Panniculitides are a diverse group of problems involving inflammation of subcutaneous fat. Subcutaneous fat has limited ability to show different patterns of disease and therefore the clinical appearance is the same but has different etiologies. The skin appears red or purple, swollen, may have discrete nodule(s) or plaque(s) and the affected area can be painful or pruritic. If necessary skin biopsy can help determine the etiology. Overall panniculitides are not very common but some presentations are expected because of particular exposure (i.e. cold) or inflammatory disease processes.
Types of panniculitides in...
Source: PediatricEducation.org - August 22, 2022 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news
[Ad hoc announcement pursuant to Art. 53 LR] Roche achieves good results in the first six months of 2022
Basel, 21 July 2022Group sales up 5%1 at constant exchange rates (CER) and 5% in Swiss francsPharmaceuticals Divisionsales increase 3%; continued strong demand for new medicines to treat severe diseases; as expected, the impact of biosimilars slows down furtherDiagnostics Divisionsales grow 11%; ongoing strong base business; demand for COVID-19 tests is expected to decline in the second half of the yearIFRSnet income increases by 12% (12% in Swiss francs), whilecore earnings per share are up 11%Highlights in the second quarter:EU approvals ofPolivy (first-line treatment for aggressive form of blood cancer),Lunsumio (follic...
Source: Roche Media News - July 21, 2022 Category: Pharmaceuticals Source Type: news
[Ad hoc announcement pursuant to Art. 53 LR] Roche achieves good results in the first six months of 2022
Group sales up 5%1 at constant exchange rates (CER) and 5% in Swiss francsPharmaceuticals Divisionsales increase 3%; continued strong demand for new medicines to treat severe diseases; as expected, the impact of biosimilars slows down furtherDiagnostics Divisionsales grow 11%; ongoing strong base business; demand for COVID-19 tests is expected to decline in the second half of the yearIFRSnet income increases by 12% (12% in Swiss francs), whilecore earnings per share are up 11%Highlights in the second quarter:EU approvals ofPolivy (first-line treatment for aggressive form of blood cancer),Lunsumio (follicular lymphoma) andT...
Source: Roche Investor Update - July 21, 2022 Category: Pharmaceuticals Source Type: news
Noah Wilson-Rich: How city habitats help honeybees to thrive
On a rooftop garden in the middle of Manhattan, honeybee colonies are flourishing. Biologist Noah-Wilson Rich explains how collecting data from honeybee hives can help ensure a healthy future for all.(Image credit: Karchmer Photography / TED) (Source: NPR Health and Science)
Source: NPR Health and Science - July 15, 2022 Category: Consumer Health News Authors: Rachel Faulkner Source Type: news
Why have Australian honeybees been put into lockdown? Podcast
The varroa mite, a deadly honeybee parasite, has finally found its way into Australia.Varroa destructoraffects every other major beekeeping area in the world, damaging honeybees and transmitting viruses across hives. Now, in a fight to contain the mite, the state of New South Wales has destroyed 1,533 infected hives and implemented a statewide standstill on bee movement. Madeleine Finlay speaks to Dr Cooper Schouten, a beekeper and researcher, about why the mite poses such a threat to honeybees, what it means to put bees into lockdown, and what impacts this biosecurity breech could have.Archive: 7News Australia, WSPA 7News...
Source: Guardian Unlimited Science - July 12, 2022 Category: Science Authors: Presented and produced by Madeleine Finlay with additional production by Anand Jagatia, sound design by Rudi Zygadlo, and the executive producer was Lorna Stewart Tags: Science Environment Bees Insects Wildlife Australia news Source Type: news
